SCHEMBL23861573

SCHEMBL23861573

Oc1cc(C(c2ccccc2)(c2ccccc2)c2cc(O)c3ccccc3c2O)c(O)c2ccccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ THRB P10828 1/20 0.47
▸ LMNA P02545 1/20 0.47
▸ HTT P42858 1/20 0.47
▸ CYP2C9 P11712 3/20 0.43
▸ HSD17B10 Q99714 3/20 0.43
▸ HPGD P15428 2/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ CYP2D6 P10635 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ HIF1A Q16665 1/20 0.43
▸ MCL1 Q07820 2/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ NSD2 O96028 1/20 0.42
▸ POLB P06746 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ TRPM4 Q8TD43 1/20 0.41
▸ IDO1 P14902 1/20 0.39
▸ NQO2 P16083 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23861571 0.81 HSD17B10 (0.45) THRBLMNAHTTCYP2C9HSD17B10
SCHEMBL23861546 0.81 LMNA (0.48) THRBLMNAHTTCYP2C9HSD17B10
SCHEMBL18308670 0.76 IDO1 (0.54) THRBCYP2C9HSD17B10HPGDCYP1A2
SCHEMBL7520146 0.76 LMNA (0.55) THRBLMNAHTTCYP2C9HSD17B10
SCHEMBL7032993 0.76 LMNA (0.50) THRBLMNAHTTMCL1KDM4E
SCHEMBL23861626 0.74 THRB (0.44) THRBLMNAHTTCYP2C9HSD17B10
SCHEMBL23861570 0.73 IDO1 (0.44) THRBLMNAHTTCYP2C9HSD17B10
SCHEMBL23861498 0.72 LMNA (0.46) THRBLMNAHTTMCL1KDM4E
SCHEMBL30035564 0.70 ALDH1A1 (0.52) LMNACYP2C9HSD17B10HPGDCYP1A2
SCHEMBL584286 0.70 ALDH1A1 (0.52) LMNACYP2C9HSD17B10HPGDCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11130724-B2 Compound, resin, composition, resist pattern formation method, and circuit pattern formation method MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2021-09-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11130724-B2 Compound, resin, composition, resist pattern formation method, and circuit pattern formation method RER1, NBAS, INTS9 THRB 2019/4885LMNA 3097/4885HTT 2072/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback